Bevacizumab + Paclitaxel + Capecitabine in Triple Negative Metastatic Breast Cancer
This study is ongoing, but not recruiting participants.
Sponsor:
ARCAGY/ GINECO GROUP
Information provided by (Responsible Party):
ARCAGY/ GINECO GROUP
ClinicalTrials.gov Identifier:
NCT01069796
First received: February 16, 2010
Last updated: April 19, 2012
Last verified: April 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | December 2015 |
| Primary Completion Date: | March 2012 (Final data collection date for primary outcome measure) |